Capstone Investment Advisors’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-42,260
Closed -$164K 916
2021
Q3
$164K Buy
+42,260
New +$164K ﹤0.01% 661